China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics

China Pharma Holdings, Inc. (CPHI): $0.15

0.01 (+3.89%)

POWR Rating

Component Grades








Add CPHI to Watchlist
Sign Up

Industry: China




#23 of 49

in industry

CPHI Price/Volume Stats

Current price $0.15 52-week high $2.46
Prev. close $0.14 52-week low $0.11
Day low $0.14 Volume 75,991
Day high $0.15 Avg. volume 546,421
50-day MA $0.21 Dividend yield N/A
200-day MA $0.50 Market Cap 1.68M

CPHI Stock Price Chart Interactive Chart >

CPHI Stock Summary

  • CHINA PHARMA HOLDINGS INC's market capitalization of $1,589,159 is ahead of merely 0.36% of US-listed equities.
  • With a price/sales ratio of 0.2, CHINA PHARMA HOLDINGS INC has a higher such ratio than merely 6.47% of stocks in our set.
  • The volatility of CHINA PHARMA HOLDINGS INC's share price is greater than that of 94.14% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to CPHI, based on their financial statements, market capitalization, and price volatility, are SLQT, NAOV, BOXL, ALPP, and OPAD.
  • CPHI's SEC filings can be seen here. And to visit CHINA PHARMA HOLDINGS INC's official web site, go to

CPHI Valuation Summary

  • In comparison to the median Healthcare stock, CPHI's price/sales ratio is 95% lower, now standing at 0.2.
  • Over the past 243 months, CPHI's EV/EBIT ratio has gone up 84.3.

Below are key valuation metrics over time for CPHI.

Stock Date P/S P/B P/E EV/EBIT
CPHI 2023-09-22 0.2 0.4 -0.5 -3.1
CPHI 2023-09-21 0.2 0.4 -0.5 -3.1
CPHI 2023-09-20 0.2 0.4 -0.5 -3.2
CPHI 2023-09-19 0.2 0.4 -0.5 -3.1
CPHI 2023-09-18 0.2 0.4 -0.5 -3.1
CPHI 2023-09-15 0.2 0.4 -0.5 -3.2

CPHI Growth Metrics

    Its 5 year cash and equivalents growth rate is now at -88.76%.
  • The 3 year cash and equivalents growth rate now stands at 91.69%.
  • Its 5 year revenue growth rate is now at -35.86%.
Over the past 49 months, CPHI's revenue has gone down $4,863,116.

The table below shows CPHI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 8.07246 -1.192251 -3.689376
2022-06-30 8.085156 -1.86222 -3.725272
2022-03-31 8.887559 -0.852361 -3.661639
2021-12-31 9.641925 -0.249838 -3.399476
2021-09-30 9.683661 0.283142 -3.627794
2021-06-30 10.1057 0.5096 -3.811021

CPHI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CPHI has a Quality Grade of C, ranking ahead of 56.06% of graded US stocks.
  • CPHI's asset turnover comes in at 0.493 -- ranking 88th of 677 Pharmaceutical Products stocks.
  • DRNA, ONVO, and CASI are the stocks whose asset turnover ratios are most correlated with CPHI.

The table below shows CPHI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.493 0.094 -0.236
2021-03-31 0.538 0.177 -0.174
2020-12-31 0.495 0.180 -0.168
2020-09-30 0.494 0.153 -1.332
2020-06-30 0.407 0.183 -0.990
2020-03-31 0.306 0.105 -0.802

CPHI Latest News Stream

Event/Time News Detail
Loading, please wait...

CPHI Latest Social Stream

Loading social stream, please wait...

View Full CPHI Social Stream

Latest CPHI News From Around the Web

Below are the latest news stories about CHINA PHARMA HOLDINGS INC that investors may wish to consider to help them evaluate CPHI as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers are a hot topic this morning and we're checking on the biggest ones investors will want to watch on Friday!

William White on InvestorPlace | September 22, 2023

Is China Pharma Holding (CPHI) A Hidden Gem or A Value Trap?

Unraveling the Financial Health of China Pharma Holding

Yahoo | August 23, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the week off right with a look at the biggest pre-market stock movers worth watching on Monday morning!

William White on InvestorPlace | August 21, 2023

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its wholly-owned subsidiary Hainan Helpson Medical & Biotechnology Co., Ltd. (hereinafter referred to as "Helpson") has received the "Drug Supplementary Application Approval Notice" for its candesartan tablets by National Medical Products Administration of China (hereinafter referred to as NMPA"), indicating that the Company's candesartan tablets hav

Yahoo | August 9, 2023

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock split on its common stock effective Monday, March 6, 2023, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the common stock will continue on the NYSE American under the symbol "CPHI". The new CUSIP number for the common stock following the reverse stock split is 16941T-203.

Yahoo | February 24, 2023

Read More 'CPHI' Stories Here

CPHI Price Returns

1-mo N/A
3-mo -56.33%
6-mo N/A
1-year -89.74%
3-year -95.99%
5-year -93.33%
YTD -84.36%
2022 -80.13%
2021 8.25%
2020 88.26%
2019 -7.86%
2018 42.78%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!